Finasteride treatment for one year in 35 hirsute patients

被引:23
作者
Bayram, F [1 ]
Müderris, II
Sahin, Y
Kelestimur, F
机构
[1] Erciyes Univ, Fac Med, Dept Endocrinol, TR-38039 Kayseri, Turkey
[2] Erciyes Univ, Fac Med, Dept Obstet & Gynecol, TR-38039 Kayseri, Turkey
关键词
finasteride; hirsutism;
D O I
10.1055/s-0029-1212097
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study was performed to confirm the favourable therapeutic effects of finasteride in hirsute women as described by previous publications of different research groups. Our study was a non-randomized, prospective clinical trial. Thirty five patients with hirsutism were included in the study. The patients received 5 mg finasteride orally once per day over a period of 12 months. Hirsutism score, FSH, LH, E-2, total T, free T, androstenedione (A), DHEAS, 17-hydroxyprogesterone (17-OHP) and sex hormone-binding globulin (SHBG) levels were determined in all the patients before treatment and every 6 months during treatment. The modified Ferriman-Gallwey score decreased from a mean of 19.06 +/-. 6.12 to 11.31 +/- 4.93 during the study. Clinical improvement in the degree of hirsutism was observed in 26 of 35 patients. The percent reductions in hirsutism scores (mean% +/- SD) at 6 and at 12 months were 25.8 +/- 11.3 and 41.3 +/- 18.5, respectively. During the finasteride therapy E2 and SHBG were increased significantly while DHEAS was decreased significantly at 12 months. There were no significant changes in the values of the other hormones and no serious side effects were observed in the study. In conclusion, finasteride is a well tolerated therapeutic agent without significant side pathological laboratory findings and can be used in the treatment of hirsutism.
引用
收藏
页码:195 / 197
页数:3
相关论文
共 16 条
[1]   Outcome of long-term treatment with the 5 alpha-reductase inhibitor finasteride in idiopathic hirsutism: Clinical and hormonal effects during a 1-year course of therapy and 1-year follow-up [J].
Castello, R ;
Negri, C ;
Tosi, F ;
Muggeo, M ;
Perrone, F ;
Moghetti, P .
FERTILITY AND STERILITY, 1996, 66 (05) :734-740
[2]   CLINICAL AND ENDOCRINE EFFECTS OF FINASTERIDE, A 5-ALPHA-REDUCTASE INHIBITOR, IN WOMEN WITH IDIOPATHIC HIRSUTISM [J].
CIOTTA, L ;
CIANCI, A ;
CALOGERO, AE ;
PALUMBO, MA ;
MARLETTA, E ;
SCIUTO, A ;
PALUMBO, G .
FERTILITY AND STERILITY, 1995, 64 (02) :299-306
[3]   HIRSUTISM - PRACTICAL THERAPEUTIC GUIDELINES [J].
DELAHUNT, JW .
DRUGS, 1993, 45 (02) :223-231
[4]   EFFECTS OF FINASTERIDE, A 5-ALPHA-REDUCTASE INHIBITOR, ON CIRCULATING ANDROGENS AND GONADOTROPIN-SECRETION IN HIRSUTE WOMEN [J].
FRUZZETTI, F ;
DELORENZO, D ;
PARRINI, D ;
RICCI, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (03) :831-835
[5]   USE OF CYPROTERONE-ACETATE (CPA) IN TREATMENT OF ACNE, HIRSUTISM AND VIRILISM [J].
HAMMERSTEIN, J ;
MECKIES, J ;
LEOROSSBERG, I ;
MOLTZ, L ;
ZIELSKE, F .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1975, 6 (06) :827-836
[6]   HIRSUTISM - IMPLICATIONS, ETIOLOGY, AND MANAGEMENT [J].
HATCH, R ;
ROSENFIELD, RL ;
KIM, MH ;
TREDWAY, D .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1981, 140 (07) :815-830
[7]   Comparison of Diane 35 and Diane 35 plus spironolactone in the treatment of hirsutism [J].
Kelestimur, F ;
Sahin, Y .
FERTILITY AND STERILITY, 1998, 69 (01) :66-69
[8]  
LEPHART ED, 1982, J STEROID BIOCHEM, V42, P439
[9]   CLINICAL AND HORMONAL EFFECTS OF THE 5-ALPHA-REDUCTASE INHIBITOR FINASTERIDE IN IDIOPATHIC HIRSUTISM [J].
MOGHETTI, P ;
CASTELLO, R ;
MAGNANI, CM ;
TOSI, F ;
NEGRI, C ;
ARMANINI, D ;
BELLOTTI, G ;
MUGGEO, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (04) :1115-1121
[10]  
Muderris II, 1996, FERTIL STERIL, V66, P220